Substance Profile and Chemical Analysis of 1Fe-LSD
The compound 1-Ferrocene-LSD is an innovative research compound belonging to the lysergamide family. From a structural perspective, this derivative is built upon the established ergoline framework.
Evolution: The new reference standard for blotters
For analytical in-vitro research on paper carriers, the 1Fe-LSD blotter represents the current legal gold standard. It fully replaces the following precursor substances that have been restricted by recent regulatory updates:
1S-LSD1T-LSD1D-LSD1V-LSD1B-LSD1cP-LSD1P-LSDALD-52 (1A-LSD)
Our impregnation process follows strict GLP guidelines to ensure consistent physicochemical properties during dissolution from the specialized paper for your analytical needs.
Legal framework and chemical classification
The legal classification of 1Fe-LSD is primarily based on the unique chemical modification at the indole nitrogen.
- This position features a specific cycloalkylcarbonyl ring containing a ferrocene component. This cycloalkyldimethylcarbonyl residue distinguishes the molecule significantly from regulated substances, allowing for the exploration of its unique pharmacokinetics within a legal framework.
Pharmacology and the prodrug principle
In chemical and functional terms, 1Fe-LSD is categorized as a prodrug. This implies:
- The molecule itself demonstrates little to no significant pharmacological activity.
- It is transformed into the active “parent substance” only via in-vivo processes (enzymatic hydrolysis).
- This mechanism is well-documented in research involving 1S-LSD, 1D-LSD, or 1V-LSD.
Research data: Comparing 1Fe-LSD to 1S-LSD and ALD-52
While 1Fe-LSD is metabolically processed in a similar manner to 1S-LSD or 1P-LSD, current research indicates distinct differences in its profile:
- Rapid Onset: Studies have observed a shorter time to peak (onset) compared directly to 1S-LSD.
- Stability: The ferrocene group provides specific molecular stability characteristics, making it particularly valuable for comparative studies involving ALD-52.
Dosage calculation and molecular equivalence
Precision in research requires careful consideration of molar mass. Because 1Fe-LSD has a higher molecular weight than older derivatives due to the ferrocene moiety, the substance amount must be mathematically adjusted.
Based on initial data, the following equivalence applies. 200mcg of 1Fe-LSD corresponds to a theoretical release of approximately:
| Baseline Value | Theoretical Equivalence |
|---|---|
| 200mcg 1Fe-LSD | approx. 150mcg 1S-LSD |
| 200mcg 1Fe-LSD | approx. 125mcg 1P-LSD |
| 200mcg 1Fe-LSD | approx. 100mcg classical LSD-25 |
Expert laboratory guidelines and storage
Since 1Fe-LSD is a complex organic compound, correct laboratory handling is vital for the integrity of your results. Optimal storage conditions: Lysergamides are generally stable against light (UV), oxygen, and moderate heat.
- Temperature: For long-term studies, we suggest storage at room temperature in amber glass. For short-term experiments, dry storage is sufficient.
- Moisture: Protect blotters from condensation. If using refrigeration, ensure containers are airtight and allow them to reach room temperature before opening to avoid moisture buildup on the carrier material.
- Protection: Ideally, use amber glass for light protection.
- Handling: Our 200mcg blotters are deeply impregnated. However, laboratory gloves should be used to prevent skin oils from contaminating the chemical purity of the sample during analysis.
- Molecular Mass: The 200mcg weight refers to the total 1Fe-LSD-tartrate mass. For molar comparisons with LSD-25, account for the weight of the ferrocene attachment using the equivalence table above.
Technical Specifications & Specs
| Formula | C31H34N3O2Fe |
|---|---|
| Molar Mass | 536.46 g/mol |
| IUPAC Name | (8β)-1-ferrocenecarbonyl-N,N-diethyl-6-methyl-9,10-didehydroergoline-8-carboxamide hemi-L-tartrate |
| CAS Number | N/A (New development) |
| Form | Blotters (Art), printed with “1Fe-LSD” |
Legal Information and Safety
1Fe-LSD is distributed strictly and exclusively for laboratory research purposes. This product is expressly not approved for in-vivo experiments on animals or for human consumption.
- BtMG Compliance: Contains no substances listed in the BtMG schedules (as of 19.12.2025).
- NpSG Compliance: Not covered by the New Psychoactive Substances Act (as of 02.12.2025).
- AMG: Not classified as a medicinal product.
- Jurisdiction: Law enforcement agencies have no jurisdiction over this substance.
Please follow standard safety protocols for handling laboratory chemicals (gloves, protective eyewear).
Click here to view all lysergamides available in our shop.








Reviews
There are no reviews yet.